Southampton, United Kingdom

John Horton

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vantia Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Horton. Retrieved from https://idiyas.com/inventor/john-horton-mzbxhd4h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Horton - Innovator in Cancer Treatment

Introduction

John Horton is a notable inventor based in Southampton, GB. He has made significant contributions to the field of cancer treatment through his innovative work. His dedication to research and development has led to the creation of valuable compounds that hold promise for medical advancements.

Latest Patents

John Horton holds a patent for FAP inhibitors. The present invention concerns compounds, according to general formula (I), which find utility preferably for the treatment of cancer. This patent highlights his commitment to addressing critical health challenges through scientific innovation.

Career Highlights

John Horton is associated with Vantia Limited, where he applies his expertise in developing therapeutic solutions. His work at the company reflects his passion for improving patient outcomes and advancing medical science.

Collaborations

John has collaborated with talented individuals such as Julie Elizabeth Trim and David Michael Evans. These partnerships enhance the innovative environment at Vantia Limited and contribute to the success of their projects.

Conclusion

John Horton is a dedicated inventor whose work in developing FAP inhibitors showcases his commitment to cancer treatment. His contributions to Vantia Limited and collaborations with esteemed colleagues further emphasize his impact in the field of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…